Xiangyong Li

1.2k total citations
53 papers, 838 citations indexed

About

Xiangyong Li is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Xiangyong Li has authored 53 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 17 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in Xiangyong Li's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (13 papers) and Hepatitis B Virus Studies (12 papers). Xiangyong Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (13 papers) and Hepatitis B Virus Studies (12 papers). Xiangyong Li collaborates with scholars based in China, Canada and United States. Xiangyong Li's co-authors include Xudong Tang, Keyuan Zhou, Yuankai Wu, Yuefei Zhang, Yusheng Jie, Yutian Chong, Guoli Lin, Jing X. Kang, Qunzhou Zhang and Yun Yen and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Xiangyong Li

51 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyong Li China 16 290 196 170 163 149 53 838
Takako Nomura Japan 21 446 1.5× 262 1.3× 171 1.0× 217 1.3× 197 1.3× 78 1.2k
Csilla Páska Hungary 16 408 1.4× 162 0.8× 156 0.9× 118 0.7× 260 1.7× 27 1.1k
Gabriella B. Gajdos United States 15 440 1.5× 182 0.9× 110 0.6× 216 1.3× 152 1.0× 20 975
Jessica L. Maiers United States 12 408 1.4× 283 1.4× 76 0.4× 133 0.8× 54 0.4× 21 953
Lan Zhong China 18 521 1.8× 99 0.5× 121 0.7× 65 0.4× 150 1.0× 50 983
Chong Huang China 18 397 1.4× 288 1.5× 44 0.3× 135 0.8× 205 1.4× 46 809
Sainan Zhang China 18 372 1.3× 155 0.8× 70 0.4× 117 0.7× 140 0.9× 83 1.0k
Longfeng Jiang China 16 300 1.0× 235 1.2× 64 0.4× 169 1.0× 93 0.6× 42 790
Richard G. Ruddell Australia 11 241 0.8× 304 1.6× 68 0.4× 319 2.0× 76 0.5× 15 1.1k

Countries citing papers authored by Xiangyong Li

Since Specialization
Citations

This map shows the geographic impact of Xiangyong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyong Li more than expected).

Fields of papers citing papers by Xiangyong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyong Li. The network helps show where Xiangyong Li may publish in the future.

Co-authorship network of co-authors of Xiangyong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyong Li. A scholar is included among the top collaborators of Xiangyong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyong Li. Xiangyong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiangyong, Zeyang Zhou, Chenxi Zhou, et al.. (2024). Preoperative Albumin to Alkaline Phosphatase Ratio and Inflammatory Burden Index for Rectal Cancer Prognostic Nomogram-Construction: Based on Multiple Machine Learning. Journal of Inflammation Research. Volume 17. 11161–11174. 2 indexed citations
2.
Niu, Yonggang, et al.. (2023). Hepatic transcriptome and gut microbiome provide insights into freeze tolerance in the high-altitude frog, Nanorana parkeri. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 48. 101147–101147. 4 indexed citations
4.
Hu, Wenjia, Yan Wang, Ran Chen, et al.. (2023). MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway. Cellular Signalling. 110. 110833–110833. 4 indexed citations
5.
Hao, Lei, et al.. (2022). Omega-3 Polyunsaturated Fatty Acids Protect against High-Fat Diet-Induced Morphological and Functional Impairments of Brown Fat in Transgenic Fat-1 Mice. International Journal of Molecular Sciences. 23(19). 11903–11903. 8 indexed citations
6.
Niu, Yonggang, et al.. (2022). Physiological Ecology of Winter Hibernation by the High-Altitude Frog Nanorana parkeri. Physiological and Biochemical Zoology. 95(3). 201–211. 17 indexed citations
7.
Zhang, Haiying, Xuejing Zhang, Xiangyong Li, et al.. (2022). Effects of acute heat exposure on oxidative stress and antioxidant defenses in overwintering frogs, Nanorana parkeri. Journal of Thermal Biology. 110. 103355–103355. 12 indexed citations
8.
Xi, Sujuan, Xiaoyan Zheng, Xiangyong Li, et al.. (2021). Activated Hepatic Stellate Cells Induce Infiltration and Formation of CD163+ Macrophages via CCL2/CCR2 Pathway. Frontiers in Medicine. 8. 49 indexed citations
9.
Zhou, Xiaogen, et al.. (2021). Analysis of the effect of R-CHOP regimen of pegylated liposomal doxorubicin on elderly patients with stage Ⅲ-Ⅳ diffuse large B-cell lymphoma.. PubMed. 34(6(Special)). 2455–2459. 1 indexed citations
10.
Huang, Bingyu, Zhiyuan Zhou, Jiao Liu, et al.. (2020). The role of monoamine oxidase A in HPV-16 E7-induced epithelial-mesenchymal transition and HIF-1α protein accumulation in non-small cell lung cancer cells. International Journal of Biological Sciences. 16(14). 2692–2703. 22 indexed citations
11.
Liu, Yu, et al.. (2020). Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis‐Autoimmune Hepatitis Overlap Syndrome. BioMed Research International. 2020(1). 1934541–1934541. 7 indexed citations
13.
Wang, Ying, Xiangyong Li, Lili Wu, et al.. (2019). Dynamic prediction of liver cirrhosis risk in chronic hepatitis B patients using longitudinal clinical data. European Journal of Gastroenterology & Hepatology. 32(1). 120–126. 1 indexed citations
14.
Han, Jing, Lynnette Marcar, Joshua C. Black, et al.. (2017). Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway. Cancer Research. 77(8). 2018–2028. 77 indexed citations
15.
Huang, Mingxing, Yusheng Jie, Hong Shi, et al.. (2015). Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China.. PubMed. 8(1). 666–73. 12 indexed citations
16.
17.
Li, Xiangyong, et al.. (2013). Epigallocatechin-3-Gallate Inhibits IGF-I-Stimulated Lung Cancer Angiogenesis through Downregulation of HIF-1α and VEGF Expression. Lifestyle Genomics. 6(3). 169–178. 54 indexed citations
18.
Li, Xiangyong, Yuankai Wu, Guoli Lin, et al.. (2013). Efficacy of Entecavir Treatment for up to 5 Years in Nucleos(t)ide-Naïve Chronic Hepatitis B Patients in Real Life. International Journal of Medical Sciences. 10(4). 427–433. 47 indexed citations
19.
Liang, Yan, Xiangyong Li, Xin Zhang, et al.. (2012). Combinatorial gene targeting hTERT and BI-1 in CNE-2 nasopharyngeal carcinoma cell line. Biomedical Reports. 1(2). 285–293. 1 indexed citations
20.
Li, Xiangyong, Yiu‐Kay Lai, Jinfang Zhang, et al.. (2011). Lentivirus-Mediated RNA Interference Targeting Bax Inhibitor-1 Suppresses Ex Vivo Cell Proliferation and In Vivo Tumor Growth of Nasopharyngeal Carcinoma. Human Gene Therapy. 22(10). 1201–1208. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026